Journal article · 2013 · Open access

Patient-Reported Outcomes (Pros) In Antidiabetic Product Approvals In Europe And In The Usa

M. Caron, M.P. Emery, L.L. Perrier, Catherine Acquadro, M.P. Excanez-Virieux

Value in Health, 16(3), A169–A170 · Published 1 May 2013 · DOI 10.1016/j.jval.2013.03.848

Open full textCite this paper

In brief

“Patient-Reported Outcomes (Pros) In Antidiabetic Product Approvals In Europe And In The Usa” is a 2013 journal article by M. Caron and 4 co-authors, published in Value in Health. OpenAlex counts 0 citations as of 22 November 2026. It is open access: the full text is free to read at Value in Health.

Citations
0
Authors
5

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Caron, M., Emery, M., Perrier, L., Acquadro, C., & Excanez-Virieux, M. (2013). Patient-Reported Outcomes (Pros) In Antidiabetic Product Approvals In Europe And In The Usa. Value in Health, 16(3), A169–A170. https://doi.org/10.1016/j.jval.2013.03.848

MLA 9

Caron, M., et al. “Patient-Reported Outcomes (Pros) In Antidiabetic Product Approvals In Europe And In The Usa.” Value in Health, vol. 16, no. 3, 2013, pp. A169–A170. https://doi.org/10.1016/j.jval.2013.03.848.

Chicago

Caron, M., M.P. Emery, L.L. Perrier, Catherine Acquadro, and M.P. Excanez-Virieux. 2013. “Patient-Reported Outcomes (Pros) In Antidiabetic Product Approvals In Europe And In The Usa.” Value in Health 16 (3): A169–A170. https://doi.org/10.1016/j.jval.2013.03.848.

Harvard

Caron, M. et al. (2013) ‘Patient-Reported Outcomes (Pros) In Antidiabetic Product Approvals In Europe And In The Usa’, Value in Health, 16(3), pp. A169–A170. doi:10.1016/j.jval.2013.03.848.

IEEE

M. Caron, M. Emery, L. Perrier, C. Acquadro, and M. Excanez-Virieux, “Patient-Reported Outcomes (Pros) In Antidiabetic Product Approvals In Europe And In The Usa,” Value in Health, vol. 16, no. 3, pp. A169–A170, 2013, doi: 10.1016/j.jval.2013.03.848.

BibTeX

@article{caron2013patient,
  title     = {{Patient-Reported Outcomes (Pros) In Antidiabetic Product Approvals In Europe And In The Usa}},
  author    = {Caron, M. and Emery, M.P. and Perrier, L.L. and Acquadro, Catherine and Excanez-Virieux, M.P.},
  journal   = {Value in Health},
  year      = {2013},
  volume    = {16},
  number    = {3},
  pages     = {A169--A170},
  doi       = {10.1016/j.jval.2013.03.848},
  url       = {https://doi.org/10.1016/j.jval.2013.03.848}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life

  • patient-reported outcomes
  • antidiabetic drugs
  • drug approval
  • regulatory differences
  • Europe
  • glycemic control

Work with this paper

Most-cited papers in Economics, Econometrics and Finance

All highly cited Economics, Econometrics and Finance papers

Questions about this paper

How do I cite this paper in APA style?

Caron, M., Emery, M., Perrier, L., Acquadro, C., & Excanez-Virieux, M. (2013). Patient-Reported Outcomes (Pros) In Antidiabetic Product Approvals In Europe And In The Usa. Value in Health, 16(3), A169–A170. https://doi.org/10.1016/j.jval.2013.03.848

How many times has this paper been cited?

0 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Value in Health: sign in and open the full text from this page.

Who wrote this paper?

M. Caron, M.P. Emery, L.L. Perrier, Catherine Acquadro, M.P. Excanez-Virieux.

What is the DOI of this paper?

10.1016/j.jval.2013.03.848, permanently at https://doi.org/10.1016/j.jval.2013.03.848. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.